Atara Biotherapeutics (ATRA) Change in Inventory (2022 - 2025)

Atara Biotherapeutics' Change in Inventory history runs 4 years deep, the most recent figure standing at -$10.7 million for Q1 2025.

• Quarterly Change in Inventory fell 267.06% year-over-year to -$10.7 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$10.7 million (down 340.3% YoY) and the FY2025 annual result came in at -$10.7 million, down 340.3% from the prior year.
• Change in Inventory was -$10.7 million for Q1 2025 at Atara Biotherapeutics, down from $160000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $6.4 million in Q1 2024 and bottomed at -$10.7 million in Q1 2025.
• A 4-year average of $348500.0 and a median of $2.1 million in 2022 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory soared 96.41% — and 2024, when it sank 275.51%.
• Atara Biotherapeutics' Change in Inventory stood at $1.6 million in 2022, then surged by 96.41% to $3.1 million in 2023, then plunged by 94.86% to $160000.0 in 2024, then slumped by 6759.38% to -$10.7 million in 2025.
• Business Quant data shows ATRA's Change in Inventory at -$10.7 million in Q1 2025, $160000.0 in Q4 2024, and -$4.8 million in Q3 2024.